Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

HF 2523

as introduced - 87th Legislature (2011 - 2012) Posted on 02/27/2012 01:08pm

KEY: stricken = removed, old language.
underscored = added, new language.

Bill Text Versions

Engrossments
Introduction Posted on 02/27/2012

Current Version - as introduced

Line numbers 1.1 1.2 1.3 1.4 1.5
1.6 1.7 1.8 1.9 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 1.21 1.22 1.23 1.24 1.25 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 2.10 2.11

A bill for an act
relating to health; requiring informed consent for certain vaccines manufactured
with or containing human DNA; proposing coding for new law in Minnesota
Statutes, chapter 145.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1.

new text begin [145.669] HUMAN DNA VACCINES; INFORMED CONSENT
REQUIRED.
new text end

new text begin Subdivision 1. new text end

new text begin Informed consent. new text end

new text begin The Minnesota Informed Consent Form must
be given to any patient or, in the case of a minor, the patient's parent or legal guardian,
if the patient is offered vaccines or medicines manufactured with or containing human
fetal or embryonic cell components, deoxyribonucleic acid (DNA), recombinant DNA,
monoclonal antibodies, proteins, or any other components derived from fetal sources. The
consent form must be made available on the Department of Health's Web site for use
by providers.
new text end

new text begin Subd. 2. new text end

new text begin Form. new text end

new text begin The form on the Department of Health's Web site must include
the following information:
new text end

new text begin "Minnesota Informed Consent Form
new text end

new text begin You are entitled to know that the following immunizations or medicines are
developed by using cell lines obtained from electively aborted fetuses. These products
contain residual DNA or cell components and proteins from a fetal cell line. In some cases
there may be an alternative that does not use residual human fetal material.
new text end

new text begin Disease
new text end
new text begin Brand Name(s)
new text end
new text begin Alternative
new text end
new text begin Chickenpox
new text end
new text begin Varivax
new text end
new text begin none in the United States
new text end
new text begin Hepatitis-A
new text end
new text begin Vaqta, Havrix
new text end
new text begin none in the United States
new text end
new text begin Hepatitis-A+B
new text end
new text begin Twinrix
new text end
new text begin Hepatitis B separately
new text end
new text begin Measles, mumps, rubella
new text end
new text begin MMR II
new text end
new text begin measles, mumps separately;
none for rubella
new text end
new text begin Polio
new text end
new text begin Pentacel
new text end
new text begin Pediarix or any polio, DTaP,
HiB separately
new text end
new text begin Rabies
new text end
new text begin Imovax
new text end
new text begin RabAvert
new text end
new text begin Shingles
new text end
new text begin Zostavax
new text end
new text begin none in the United States
new text end

new text begin This form does not replace the Vaccine Information Statements required by the
Centers for Disease Control."
new text end

new text begin This form must be updated by the Department of Health in the event that future
vaccines or medicines become available that contain residual DNA or cell components
and proteins from a fetal cell line.
new text end